---
figid: PMC5047222__peerj-04-2348-g001
figlink: /pmc/articles/PMC5047222/figure/fig-1/
number: F1
caption: The HBP (right) generates Uridine diphosphate N-acetylglucosamine (UDP-GlcNAc)
  as the end product that is used by the O-GlcNAc transferase (OGT) to covalently
  attach O-GlcNAc to hydroxyl groups of serine/threonine residues of proteins. This
  dynamic process is antagonized by O-GlcNAcase (OGA). In cancer, increased HBP flux
  leads to hyper O-GlcNAcylation. Hyper O-GlcNAcylation of c-Myc activates the phosphoinositide
  3-kinase (PI3K)-mTOR-MYC signaling axis (middle). The PI3K pathway cross-talks with
  Forkhead box M1 (FoxM1), an oncogenic transcription factor that is regulated by
  levels of O-GlcNAc and OGT (middle). Inflammatory responses to genotoxic stress
  induce activation of NF-κB that can undergo O-GlcNAcylation to mediate genes in
  the immune response (left). The loss of p53 activates NF-κB to increase aerobic
  glycolysis and support tumor metabolism. Hyper O-GlcNAcylation of p53 stabilizes
  the tumor suppressor and decreases p53-MDM2 interaction to block proteolysis (bottom).
  In response to stress, p53 can induce cyclin-dependent kinase inhibitor p21 to inhibit
  proliferation.
pmcid: PMC5047222
papertitle: 'Formal modeling and analysis of the hexosamine biosynthetic pathway:
  role of O-linked N-acetylglucosamine transferase in oncogenesis and cancer progression.'
reftext: Muhammad Tariq Saeed, et al. PeerJ. 2016;4:e2348.
pmc_ranked_result_index: '345'
pathway_score: 0.9171557
filename: peerj-04-2348-g001.jpg
figtitle: 'Formal modeling and analysis of the hexosamine biosynthetic pathway: role
  of O-linked N-acetylglucosamine transferase in oncogenesis and cancer progression'
year: '2016'
organisms: Homo sapiens
ndex: 756de036-df0f-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5047222__peerj-04-2348-g001.html
  '@type': Dataset
  description: The HBP (right) generates Uridine diphosphate N-acetylglucosamine (UDP-GlcNAc)
    as the end product that is used by the O-GlcNAc transferase (OGT) to covalently
    attach O-GlcNAc to hydroxyl groups of serine/threonine residues of proteins. This
    dynamic process is antagonized by O-GlcNAcase (OGA). In cancer, increased HBP
    flux leads to hyper O-GlcNAcylation. Hyper O-GlcNAcylation of c-Myc activates
    the phosphoinositide 3-kinase (PI3K)-mTOR-MYC signaling axis (middle). The PI3K
    pathway cross-talks with Forkhead box M1 (FoxM1), an oncogenic transcription factor
    that is regulated by levels of O-GlcNAc and OGT (middle). Inflammatory responses
    to genotoxic stress induce activation of NF-κB that can undergo O-GlcNAcylation
    to mediate genes in the immune response (left). The loss of p53 activates NF-κB
    to increase aerobic glycolysis and support tumor metabolism. Hyper O-GlcNAcylation
    of p53 stabilizes the tumor suppressor and decreases p53-MDM2 interaction to block
    proteolysis (bottom). In response to stress, p53 can induce cyclin-dependent kinase
    inhibitor p21 to inhibit proliferation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RELB
  - E2F1
  - E2F7
  - PIK3CB
  - NFKB1
  - RELA
  - REL
  - AKT2
  - CD19
  - NFKB2
  - E2F2
  - JAK1
  - MDM2
  - PIK3R6
  - PIK3R4
  - PIK3CA
  - E2F5
  - E2F6
  - E2F8
  - AKT3
  - MGEA5
  - FOXO3
  - MYC
  - CHUK
  - ILK
  - IRS1
  - PDK1
  - E2F3
  - E2F4
  - AKT1
  - MAP3K8
  - PIK3CD
  - PIK3CG
  - CDKN1A
  - TP53
  - FOXM1
  - OGT
  - PIK3R3
  - GAB2
  - PIK3R5
  - GAB1
  - PTK2
  - UDP
  - Cancer
genes:
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: CD19
  symbol: CD19
  source: hgnc_symbol
  hgnc_symbol: CD19
  entrez: '930'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: Jak-1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: OGA
  symbol: OGA
  source: hgnc_alias_symbol
  hgnc_symbol: MGEA5
  entrez: '10724'
- word: FOXO3A
  symbol: FOXO3A
  source: hgnc_prev_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: IKK-a
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: ILK
  symbol: ILK
  source: hgnc_symbol
  hgnc_symbol: ILK
  entrez: '3611'
- word: ÍRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TPL2
  symbol: Tpl-2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP3K8
  entrez: '1326'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: P21Cip1/Waf1
  symbol: p21Cip1/Waf1
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN1A
  entrez: '1026'
- word: P53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: FOXM1
  symbol: FOXM1
  source: hgnc_symbol
  hgnc_symbol: FOXM1
  entrez: '2305'
- word: OGT
  symbol: OGT
  source: hgnc_symbol
  hgnc_symbol: OGT
  entrez: '8473'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Gab-2
  symbol: GAB2
  source: hgnc_symbol
  hgnc_symbol: GAB2
  entrez: '9846'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Gab1
  symbol: GAB1
  source: hgnc_symbol
  hgnc_symbol: GAB1
  entrez: '2549'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
chemicals:
- word: UDP
  source: MESH
  identifier: D014530
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5047222__F1
redirect_from: /figures/PMC5047222__F1
figtype: Figure
---
